Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1980 1
1986 1
2006 1
2007 1
2010 2
2012 1
2013 1
2014 2
2015 1
2016 3
2017 3
2018 3
2019 5
2020 1
2021 5
2022 2
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

32 results

Results by year

Filters applied: . Clear all
Page 1
Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study.
Burtness B, Harrington KJ, Greil R, Soulières D, Tahara M, de Castro G Jr, Psyrri A, Basté N, Neupane P, Bratland Å, Fuereder T, Hughes BGM, Mesía R, Ngamphaiboon N, Rordorf T, Wan Ishak WZ, Hong RL, González Mendoza R, Roy A, Zhang Y, Gumuscu B, Cheng JD, Jin F, Rischin D; KEYNOTE-048 Investigators. Burtness B, et al. Lancet. 2019 Nov 23;394(10212):1915-1928. doi: 10.1016/S0140-6736(19)32591-7. Epub 2019 Nov 1. Lancet. 2019. PMID: 31679945 Clinical Trial.
Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial.
Mok TSK, Wu YL, Kudaba I, Kowalski DM, Cho BC, Turna HZ, Castro G Jr, Srimuninnimit V, Laktionov KK, Bondarenko I, Kubota K, Lubiniecki GM, Zhang J, Kush D, Lopes G; KEYNOTE-042 Investigators. Mok TSK, et al. Lancet. 2019 May 4;393(10183):1819-1830. doi: 10.1016/S0140-6736(18)32409-7. Epub 2019 Apr 4. Lancet. 2019. PMID: 30955977 Clinical Trial.
Osimertinib or Platinum-Pemetrexed in EGFR T790M-Positive Lung Cancer.
Mok TS, Wu Y-L, Ahn M-J, Garassino MC, Kim HR, Ramalingam SS, Shepherd FA, He Y, Akamatsu H, Theelen WS, Lee CK, Sebastian M, Templeton A, Mann H, Marotti M, Ghiorghiu S, Papadimitrakopoulou VA; AURA3 Investigators. Mok TS, et al. N Engl J Med. 2017 Feb 16;376(7):629-640. doi: 10.1056/NEJMoa1612674. Epub 2016 Dec 6. N Engl J Med. 2017. PMID: 27959700 Free PMC article. Clinical Trial.
Pembrolizumab versus paclitaxel for previously treated, advanced gastric or gastro-oesophageal junction cancer (KEYNOTE-061): a randomised, open-label, controlled, phase 3 trial.
Shitara K, Özgüroğlu M, Bang YJ, Di Bartolomeo M, Mandalà M, Ryu MH, Fornaro L, Olesiński T, Caglevic C, Chung HC, Muro K, Goekkurt E, Mansoor W, McDermott RS, Shacham-Shmueli E, Chen X, Mayo C, Kang SP, Ohtsu A, Fuchs CS; KEYNOTE-061 investigators. Shitara K, et al. Lancet. 2018 Jul 14;392(10142):123-133. doi: 10.1016/S0140-6736(18)31257-1. Epub 2018 Jun 4. Lancet. 2018. PMID: 29880231 Clinical Trial.
Lenvatinib plus pembrolizumab versus lenvatinib plus placebo for advanced hepatocellular carcinoma (LEAP-002): a randomised, double-blind, phase 3 trial.
Llovet JM, Kudo M, Merle P, Meyer T, Qin S, Ikeda M, Xu R, Edeline J, Ryoo BY, Ren Z, Masi G, Kwiatkowski M, Lim HY, Kim JH, Breder V, Kumada H, Cheng AL, Galle PR, Kaneko S, Wang A, Mody K, Dutcus C, Dubrovsky L, Siegel AB, Finn RS; LEAP-002 Investigators. Llovet JM, et al. Lancet Oncol. 2023 Dec;24(12):1399-1410. doi: 10.1016/S1470-2045(23)00469-2. Lancet Oncol. 2023. PMID: 38039993 Clinical Trial.
The implications of ABCC3 in cancer drug resistance: can we use it as a therapeutic target?
Ramírez-Cosmes A, Reyes-Jiménez E, Zertuche-Martínez C, Hernández-Hernández CA, García-Román R, Romero-Díaz RI, Manuel-Martínez AE, Elizarrarás-Rivas J, Vásquez-Garzón VR. Ramírez-Cosmes A, et al. Among authors: hernandez hernandez ca. Am J Cancer Res. 2021 Sep 15;11(9):4127-4140. eCollection 2021. Am J Cancer Res. 2021. PMID: 34659880 Free PMC article. Review.
Mexican consensus on the diagnosis and management of hepatocellular carcinoma.
González Huezo MS, Sánchez Ávila JF; Asociación Mexicana de Hepatología; Asociación Mexicana de Gastroenterología; Sociedad Mexicana de Radiología e Imagen; Sociedad Mexicana de Oncología; World Gastroenterology Organisation; Grupo Mexicano de Consenso de Carcinoma Hepatocelular. González Huezo MS, et al. Rev Gastroenterol Mex. 2014 Oct-Dec;79(4):250-62. doi: 10.1016/j.rgmx.2014.09.004. Epub 2014 Dec 6. Rev Gastroenterol Mex. 2014. PMID: 25487133 Free article. Review. English, Spanish.
Cardiometabolic Factors in Pediatric Patients with Chronic Diseases.
Villasís-Keever MA, Zurita-Cruz JN, Serret-Montoya J, de Leon-Herrera AP, Galván-Heredia P, Zepeda-Martínez CDC, Alegría-Torres G, Hernández-Hernández C, Alonso-Flores S, Barbosa-Cortes L, Arenas-Aguayo LA. Villasís-Keever MA, et al. Among authors: hernandez hernandez c. Arch Med Res. 2021 Jul;52(5):535-543. doi: 10.1016/j.arcmed.2021.01.010. Epub 2021 Feb 6. Arch Med Res. 2021. PMID: 33558078
Characterisation of crevicular fluid microbiota in primary Sjögren's syndrome.
Martínez-Nava GA, López-Reyes A, Hernández-Hernández C, Ruiz-González V, Llorente-Chávez A, Saavedra-González V, Llorente L, Hernández-Molina G. Martínez-Nava GA, et al. Among authors: hernandez hernandez c. Clin Exp Rheumatol. 2023 Dec;41(12):2458-2466. doi: 10.55563/clinexprheumatol/k3vx8u. Epub 2023 Dec 4. Clin Exp Rheumatol. 2023. PMID: 38079342 Free article.
A Custom-Made Newborn Screening Test for Wilson's Disease in Puerto Rico.
Vicario-Feliciano R, Hernández-Hernández CI, Camacho-Pastor IC, Martínez-Cruzado JC. Vicario-Feliciano R, et al. Among authors: hernandez hernandez ci. Cureus. 2022 Apr 24;14(4):e24446. doi: 10.7759/cureus.24446. eCollection 2022 Apr. Cureus. 2022. PMID: 35637795 Free PMC article.
32 results